Showing results (41-50 of 78) with videos related to
Sort By:
Pageof 8
Translational Oncology|January 28, 2014
Antidiabetic Drug Metformin Prevents Progression of Pancreatic Cancer by Targeting in Part Cancer Stem Cells and mTOR SignalingAltaf Mohammed, Naveena B Janakiram, Misty Brewer, et al.Neoplasia (New York, N.Y.)|January 12, 2013
Endogenous n-3 polyunsaturated fatty acids delay progression of pancreatic ductal adenocarcinoma in Fat-1-p48(Cre/+)-LSL-Kras(G12D/+) miceAltaf Mohammed, Naveena B Janakiram, Misty Brewer, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 17, 2014
Raloxifene and antiestrogenic gonadorelin inhibits intestinal tumorigenesis by modulating immune cells and decreasing stem-like cellsNaveena B Janakiram, Altaf Mohammed, Misty Brewer, et al.Neoplasia (New York, N.Y.)|September 29, 2012
Inhibition of pancreatic intraepithelial neoplasia progression to carcinoma by nitric oxide-releasing aspirin in p48(Cre/+)-LSL-Kras(G12D/+) miceChinthalapally V Rao, Altaf Mohammed, Naveena B Janakiram, et al.Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2010
Chemopreventive effects of Frondanol A5, a Cucumaria frondosa extract, against rat colon carcinogenesis and inhibition of human colon cancer cell growthNaveena B Janakiram, Altaf Mohammed, Yuting Zhang, et al.American Journal of Cancer Research|December 23, 2015
TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinomaVenkateshwar Madka, Altaf Mohammed, Qian Li, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 9, 2019
Bisphosphonates Zometa and Fosamax Synergize with Metformin to Prevent AOM-Induced Colon Cancer in F344 Rat ModelVenkateshwar Madka, Gaurav Kumar, Gopal Pathuri, et al.Cancer Prevention Research (Philadelphia, Pa.)|November 19, 2010
The epidermal growth factor receptor inhibitor gefitinib prevents the progression of pancreatic lesions to carcinoma in a conditional LSL-KrasG12D/+ transgenic mouse modelAltaf Mohammed, Naveena B Janakiram, Qian Li, et al.Oncotarget|October 3, 2015
Simultaneous targeting of 5-LOX-COX and EGFR blocks progression of pancreatic ductal adenocarcinomaChinthalapally V Rao, Naveena B Janakiram, Venkateshwar Madka, et al.Molecular Carcinogenesis|July 18, 2019
Targeting cholecystokinin-2 receptor for pancreatic cancer chemopreventionAltaf Mohammed, Naveena B Janakiram, Chen Suen, et al.Pageof 8